Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer.
D001202:Ascitic Fluid / Q000032:analysis*; D002277:Carcinoma / Q000032:analysis*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000032:analysis*
D005338:Fibrin Fibrinogen Degradation Products